Most Clicked StoriesMore >


CMS should leave successful Medicare Part D untouched

PCMA SmartBrief | Sep 25, 2014

The CMS doesn't need more input to understand that proposed changes to Medicare Part D aren't needed because the prescription drug program is working, Doug Schoen writes. The CMS has no good reason to amend the program's noninterference clause and doing so would hurt the nation's most vulnerable patients, bringing premium hikes and cutting into Part D savings, Schoen writes. Forbes (09/24)


Sales calls shift from docs to administrators who create formularies

PCMA SmartBrief | Sep 25, 2014

Unpopular Part D proposals will not be reintroduced, CMS chief says

PCMA SmartBrief | Sep 29, 2014

OIG says drug manufacturers at risk of sanctions on copay coupons

PCMA SmartBrief | Sep 23, 2014

Drugmakers eye biosimilars market

PCMA SmartBrief | Sep 29, 2014

Hydrocodone-containing products poised for tighter controls

PCMA SmartBrief | Sep 26, 2014

CMS administrator: No plans to reintroduce withdrawn Part D proposals

PCMA SmartBrief | Sep 24, 2014

Some states reconsider opposition to Medicaid expansion

PCMA SmartBrief | Sep 26, 2014

Some pharma deals may be put off after U.S. clampdown on inversions

PCMA SmartBrief | Sep 24, 2014

Insurers streamline Part D offerings for next year

PCMA SmartBrief | Sep 23, 2014


Find PCMA SmartBrief Issues by Date:





Sign up for PCMA SmartBrief



Designed specifically for PBM industry professionals, PCMA SmartBrief is a FREE, daily e-mail newsletter. It provides the the most relevant and actionable PBM industry news in a quick, easy to read format. Learn more